Niagen Bioscience, Inc.
US ˙ NasdaqCM ˙ US1710774076

SecurityNAGE / Niagen Bioscience, Inc.
InstitutionWolverine Trading, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Wolverine Trading, Llc ownership in NAGE / Niagen Bioscience, Inc.

On November 14, 2024 - Wolverine Trading, Llc filed a 13F-HR form disclosing ownership of 0 shares of Niagen Bioscience, Inc. (US:NAGE) valued at $0 USD as of September 30, 2024. The entity filed a previous 13F-HR on August 14, 2024 disclosing 28,841 shares of Niagen Bioscience, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Wolverine Trading, Llc has a history of taking positions in derivatives of the underlying security (NAGE) in the form of stock options. The firm currently holds call options representing 31,200 of underlying shares valued at $308,880 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

NAGE / Niagen Bioscience, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2024-11-14 2024-09-30 13F CHROMADEX COM NEW 171077407 0 -28,841 -100.00 0 -100.00
2024-08-14 2024-06-30 13F CHROMADEX COM NEW 171077407 28,841 -15,278 -34.63 79 -49.02 0.0001
2024-05-15 2024-03-31 13F CHROMADEX COM NEW 171077407 44,119 44,119 154 0.0002
2021-11-12 2021-09-30 13F CHROMADEX COM NEW 171077407 0 -11,916 -100.00 0 -100.00
2021-08-06 2021-06-30 13F CHROMADEX COM NEW 171077407 11,916 11,916 113 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F NIAGEN BIOSCIENCE COM NEW Call 31,200 48.57 309 3.36 n/a n/a n/a
2025-08-18 2025-06-30 13F NIAGEN BIOSCIENCE COM NEW Call 21,000 -29.53 299 48.26 n/a n/a n/a
2025-05-15 2025-03-31 13F NIAGEN BIOSCIENCE COM NEW Call 29,800 119.12 202 171.62 n/a n/a n/a
2025-02-14 2024-12-31 13F CHROMADEX COM NEW Call 13,600 10.57 74 60.87 n/a n/a n/a
2024-11-14 2024-09-30 13F CHROMADEX COM NEW Call 12,300 47 n/a n/a n/a
2022-08-15 2022-06-30 13F CHROMADEX COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F CHROMADEX COM NEW Call 19,800 51 n/a n/a n/a
2022-02-14 2021-12-31 13F CHROMADEX COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-12 2021-09-30 13F CHROMADEX COM NEW Call 16,600 100 n/a n/a n/a
2021-08-06 2021-06-30 13F CHROMADEX COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-14 2021-03-31 13F CHROMADEX COM NEW Call 12,600 111 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F NIAGEN BIOSCIENCE COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-18 2025-06-30 13F NIAGEN BIOSCIENCE COM NEW Put 11,800 168 n/a n/a n/a
2022-02-14 2021-12-31 13F CHROMADEX COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-12 2021-09-30 13F CHROMADEX COM NEW Put 22,800 -8.06 138 -41.53 n/a n/a n/a
2021-08-06 2021-06-30 13F CHROMADEX COM NEW Put 24,800 14.81 236 24.21 n/a n/a n/a
2021-05-14 2021-03-31 13F CHROMADEX COM NEW Put 21,600 190 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.